Revolution Medicines, Inc. (RVMD)
148.63
-0.64
(-0.43%)
USD |
NASDAQ |
Apr 17, 16:00
148.56
-0.07
(-0.05%)
After-Hours: 20:00
Revolution Medicines SG&A Expense (Quarterly) : 66.68M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Tango Therapeutics, Inc. | 9.763M |
| AtriCure, Inc. | 78.34M |
| AbbVie, Inc. | 3.895B |
| Travere Therapeutics, Inc. | 101.69M |